Authors:
MOREAU S
COUDERT P
LASSERRE B
VALLEEGOYET D
GARDETTE D
NAVARRODELMASURE C
CHANH APH
DOSSOUGBETE V
COUQUELET J
Citation: S. Moreau et al., PHARMACOPHORE REQUIREMENTS IN NEW SERIES OF PYRIDAZINYL ALKANOIC ACIDS, N-[(PYRIDAZIN-2-YL)ALKYL]SUCCINYL AND GLUTARYL AMIDES, INHIBITORS OF THROMBOXANE A(2) BIOSYNTHESIS, Prostaglandins, leukotrienes and essential fatty acids, 56(6), 1997, pp. 431-436
Authors:
LEMAIRE L
MALETMARTINO MC
MARTINO R
DEFORNI M
LASSERRE B
Citation: L. Lemaire et al., THE TRIS FORMULATION OF FLUOROURACIL IS MORE CARDIOTOXIC THAN THE SODIUM-SALT FORMULATIONS, Oncology Reports, 1(1), 1994, pp. 173-174
Authors:
LASSERRE B
MAVEL S
COUDERT P
CHANH APH
NAVARRODELMASURE C
DOSSOUGBETE V
COUQUELET J
Citation: B. Lasserre et al., THROMBOXANE A(2) BIOSYNTHESIS INHIBITORS - SYNTHESIS AND EVALUATION OF PYRAZOLOTRIAZINYL ALKANOIC ACIDS, Prostaglandins, leukotrienes and essential fatty acids, 51(3), 1994, pp. 157-161
Citation: J. Vibes et al., INHIBITION OF THROMBOXANE-A(2) BIOSYNTHESIS IN-VITRO BY THE MAIN COMPONENTS OF CRATAEGUS-OXYACANTHA (HAWTHORN) FLOWER HEADS, Prostaglandins, leukotrienes and essential fatty acids, 50(4), 1994, pp. 173-175
Citation: J. Vibes et al., EFFECTS OF A METHANOLIC EXTRACT FROM CRATAEGUS-OXYACANTHA BLOSSOMS ONTXA(2) AND PGI(2) SYNTHESIZING ACTIVITIES OF CARDIAC TISSUE, Medical science research, 21(11), 1993, pp. 435-436